Previous 10 | Next 10 |
Summary Despite recent data hiccups for Guardant Health, Inc., you can expect much more upsides to this stock. The flagship Guardant360 recently gained FDA approval as a companion diagnostic for the breast-cancer drug, Orsedu. Meanwhile, Guardant also formed a strategic partnership ...
Amarin Continues to Ignore the Loud and Clear Message Sent by Shareholders at the Last Shareholder Meeting Amarin’s Misleading Words Cannot Hide Its Poor Leadership and Governance Practices That Harm and Disenfranchise Shareholders Vote the BLUE proxy card “FORȁ...
Letter Underscores the Change That is Being Led by Amarin’s New Board Highlights Sarissa’s Track Record of Value Destruction in the Healthcare Space Sarissa Continues to Mislead Shareholders by Distorting Facts and Promoting Misinformation DUBLIN, Ireland and B...
Sarissa urges all shareholders to vote the BLUE proxy card for needed change at Amarin on or prior to February 21, 2023 Do NOT vote Amarin’s WHITE proxy card Sarissa Capital Management LP (“Sarissa”) today made the following statement on Amarin C...
The shares of the Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) added ~12% on Tuesday to reach the highest level since May 2022 on above-average volume even as its largest shareholder Sarissa Capital Management seeks changes to the company’s board. Nearly 10...
DUBLIN, Ireland and BRIDGEWATER. N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (“Amarin” or the “Company”) today announced that it has mailed a letter to shareholders addressing the false and misleading statements made by Sarissa Capital...
Sarissa launches website www.freeamarin.com and posts presentation for shareholders Sarissa urges shareholders to vote the BLUE proxy card by 11:59 PM EST on February 21, 2023 Do NOT vote Amarin’s WHITE proxy card Sarissa Capital Management LP ...
Significantly Refreshed Board Overseeing Successful Execution of Amarin’s Transformation Plan to Drive Short- and Long-Term Value; Outmatches Sarissa’s Slate in Every Critical Area Chairman Per Wold-Olsen Brings Critical Experience and Leadership Releases Additiona...
Vote the Blue Card “FOR” the appointment of the Sarissa Nominees to the Board Vote the Blue Card “FOR” the Removal of Chairman Per Wold-Olsen from the Board Sarissa Capital Management LP (“Sarissa”) today issued the following letter to f...
Amarin ( NASDAQ: AMRN ) said it filed definitive proxy materials for its upcoming annual meeting on Feb. 28 as it battles with activist investor Sarissa Capital Management. Amarin ( AMRN ) is urging shareholders to vote against Sarissa's proposals. The filing comes after Saris...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...